IT1277953B1 - Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per - Google Patents
Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile perInfo
- Publication number
- IT1277953B1 IT1277953B1 IT95RM000835A ITRM950835A IT1277953B1 IT 1277953 B1 IT1277953 B1 IT 1277953B1 IT 95RM000835 A IT95RM000835 A IT 95RM000835A IT RM950835 A ITRM950835 A IT RM950835A IT 1277953 B1 IT1277953 B1 IT 1277953B1
- Authority
- IT
- Italy
- Prior art keywords
- carnitine
- polyunsatured
- alcanoyl
- pharmaceutical composition
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95RM000835A IT1277953B1 (it) | 1995-12-21 | 1995-12-21 | Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per |
PT96118681T PT780124E (pt) | 1995-12-21 | 1996-11-21 | Composicoes farmaceuticas compreendendo uma alcanoil-l-carnitina em combinacao com acidos gordos poliinsaturados da serie omega-3 para a prevencao e o tratamento das doencas do metabolismo lipidico |
DK96118681T DK0780124T3 (da) | 1995-12-21 | 1996-11-21 | Farmaceutisk præparat omfattende et alkanoyl-L-carnitin sammen med en polyumættet fedtsyre fra omega-3-serien til forebyggelse og behandling af lipidmetabolisme-lidelser |
AT96118681T ATE210977T1 (de) | 1995-12-21 | 1996-11-21 | Pharmazeutische zusammensetzung enthaltend ein alkanoyl-l-carnitin in kombination mit einer polyungesättigten fettsäure der omega-3-serie zur verhütung und behandlung von störungen des fettstoffwechsels |
ES96118681T ES2169197T3 (es) | 1995-12-21 | 1996-11-21 | Composicion farmaceutica que comprende una alcanoil l-carnitina en combinacion con un acido graso poliinsaturado de la serie omega-3 para la prevencion y el tratamiento de trastornos del metabolismo de los lipidos. |
EP96118681A EP0780124B1 (en) | 1995-12-21 | 1996-11-21 | Pharmaceutical composition comprising an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders |
DE69618158T DE69618158T2 (de) | 1995-12-21 | 1996-11-21 | Pharmazeutische Zusammensetzung enthaltend ein Alkanoyl-L-Carnitin in Kombination mit einer polyungesättigten Fettsäure der Omega-3-Serie zur Verhütung und Behandlung von Störungen des Fettstoffwechsels |
US08/755,310 US5753703A (en) | 1995-12-21 | 1996-11-22 | Pharmaceutical composition comprising L-carnitine or an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders |
TW085114597A TW522013B (en) | 1995-12-21 | 1996-11-26 | Pharmaceutical composition comprising L-carnitine or an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders |
CA002191645A CA2191645C (en) | 1995-12-21 | 1996-11-29 | Pharmaceutical composition comprising l-carnitine or an alkanoyl l-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders |
JP8335456A JPH09176005A (ja) | 1995-12-21 | 1996-12-16 | オメガ−3系のポリ不飽和脂肪酸を併用するl−カルニチンまたはアルカノイル l−カルニチン含有医薬組成物 |
KR1019960067231A KR970032853A (ko) | 1995-12-21 | 1996-12-18 | 오메가-3계열의 고도불포화지방산과 l-카르니틴 또는 알카노일 l-카르니틴을 함유하는 지질대사질환의 예방 및 치료에 유용한 약제조성물 |
ZA9610769A ZA9610769B (en) | 1995-12-21 | 1996-12-20 | Pharmaceutical composition comprising l-carnitine or an alkanoyl l-carnitine in combination with a polyunsaturated fatty acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95RM000835A IT1277953B1 (it) | 1995-12-21 | 1995-12-21 | Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per |
Publications (3)
Publication Number | Publication Date |
---|---|
ITRM950835A0 ITRM950835A0 (it) | 1995-12-21 |
ITRM950835A1 ITRM950835A1 (it) | 1997-06-21 |
IT1277953B1 true IT1277953B1 (it) | 1997-11-12 |
Family
ID=11403724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT95RM000835A IT1277953B1 (it) | 1995-12-21 | 1995-12-21 | Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per |
Country Status (13)
Country | Link |
---|---|
US (1) | US5753703A (it) |
EP (1) | EP0780124B1 (it) |
JP (1) | JPH09176005A (it) |
KR (1) | KR970032853A (it) |
AT (1) | ATE210977T1 (it) |
CA (1) | CA2191645C (it) |
DE (1) | DE69618158T2 (it) |
DK (1) | DK0780124T3 (it) |
ES (1) | ES2169197T3 (it) |
IT (1) | IT1277953B1 (it) |
PT (1) | PT780124E (it) |
TW (1) | TW522013B (it) |
ZA (1) | ZA9610769B (it) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU693312B2 (en) * | 1995-01-18 | 1998-06-25 | Taisho Pharmaceutical Co., Ltd. | Remedy for dermatitis |
IT1291113B1 (it) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito |
US6403124B1 (en) | 1997-04-16 | 2002-06-11 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Storage and maintenance of blood products including red blood cells and platelets |
US6482585B2 (en) * | 1997-04-16 | 2002-11-19 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Storage and maintenance of blood products including red blood cells and platelets |
US6090848A (en) * | 1997-12-01 | 2000-07-18 | Sigma-Tau Healthscience S.P.A. | Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans |
US5863940A (en) | 1997-12-01 | 1999-01-26 | Sigma-Tau Healthscience S.P.A. | Medicament and therapeutical method for treating idiopathic asthenozoospermia |
US20020002154A1 (en) * | 1998-02-11 | 2002-01-03 | Pol-Henri Guivarc'h | Method and composition for treatment of inflammatory conditions |
SI0951909T2 (sl) | 1998-03-19 | 2010-11-30 | Sigma Tau Ind Farmaceuti | Kombinirana zmes ki vsebuje L karnitin ali alkanoil L karnitin glikozaminoglikan in ali njegov sestavni del |
IT1299161B1 (it) * | 1998-04-17 | 2000-02-29 | Sigma Tau Healthscience Spa | Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph |
IT1302125B1 (it) * | 1998-08-03 | 2000-07-31 | Sigma Tau Healthscience Spa | Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide |
IT1308613B1 (it) * | 1999-02-17 | 2002-01-09 | Pharmacia & Upjohn Spa | Acidi grassi essenziali nella prevenzione di eventi cardiovascolari. |
IT1305308B1 (it) * | 1999-03-26 | 2001-05-04 | Biosint S P A | Granulato ad alto contenuto di l-carnitina o alcanoil-l-carnitina,particolarmente adatto alla produzione di compresse per compressione |
US8252309B2 (en) * | 2000-04-04 | 2012-08-28 | Sigma-Tau Industrie Farmaceutiche Riunite Spa | Dietary supplement energy-providing to skeletal muscles |
IT1317008B1 (it) * | 2000-04-04 | 2003-05-26 | Sigma Tau Healthscience Spa | Integratore alimentare energizzante sulla muscolatura scheletrica eprotettivo sull'apparato cardiovascolare. |
US7226916B1 (en) | 2000-05-08 | 2007-06-05 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
US7208180B2 (en) * | 2000-05-08 | 2007-04-24 | N.V. Nutricia | Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith |
ITMI20010129A1 (it) | 2001-01-25 | 2002-07-25 | Pharmacia & Upjohn Spa | Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco |
WO2003009854A1 (en) * | 2001-07-20 | 2003-02-06 | Lonza Ag | Lipid lowering composition comprising carnitine and phytosterol |
ITMI20012384A1 (it) * | 2001-11-12 | 2003-05-12 | Quatex Nv | Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori |
ES2208131B1 (es) * | 2002-03-27 | 2005-09-01 | Volker Bartz | Metodo para la fabricacion de un medicamento reductor de niveles de lipidos en sangre para la administracion oral. |
DE20214827U1 (de) | 2002-09-25 | 2003-02-20 | Bartz, Volker, 35440 Linden | Leistungsförderer für Sportler zur oralen Einnahme |
EP1466597A1 (en) * | 2003-04-07 | 2004-10-13 | Clinigenetics | Use of dha esters to control or prevent cardiovascular diseases |
WO2004091603A1 (fr) * | 2003-04-07 | 2004-10-28 | Clinigenetics | Utilisation d’un ester de dha pour le traitement des malades cardiovasculaires |
US8173618B2 (en) * | 2003-07-25 | 2012-05-08 | University Of Massachusetts | Formulations for reducing neuronal degeneration |
US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
PT1904044E (pt) * | 2005-07-08 | 2013-04-26 | Sigma Tau Ind Farmaceuti | Uso de uma combinação compreendendo l-carnitina ou alcanoil l-carnitina, benzoquinona lipossolúvel solúvel e ácidos gordos omega-3-poliinsaturados para a preparação de um suplemento dietético ou medicamento para o tratamento de doenças da córnea |
ES2500063T3 (es) | 2006-05-31 | 2014-09-29 | Mochida Pharmaceutical Co., Ltd. | Composición para prevenir la aparición de acontecimiento cardiovascular en paciente con riesgo múltiple |
WO2008093848A1 (ja) * | 2007-02-02 | 2008-08-07 | Sunstar Inc. | ホスファチジルコリンを含有する炎症マーカー低減組成物 |
US8597640B2 (en) * | 2007-10-31 | 2013-12-03 | University Of Massachusetts Lowell | Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging |
MX2011001419A (es) | 2008-08-07 | 2011-05-25 | Prodotti Antibiotici Spa | Tratamiento a largo plazo de deficiencia cardiaca sintomatica. |
SG195648A1 (en) * | 2008-11-11 | 2013-12-30 | Sigma Tau Ind Farmaceuti | Compound useful for treating cellulite |
MX2011005077A (es) * | 2008-11-14 | 2011-05-25 | Bomi P Framroze | Un metodo para reducir el complejo de lipoproteina-beta-2-glicopro teina 1 de baja densidad oxidado circulante para el tratamiento de ateroesclerosis. |
EP2384192B1 (en) * | 2009-01-05 | 2017-10-25 | Calanus AS | Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease |
US20110071090A1 (en) * | 2009-03-11 | 2011-03-24 | Stable Solutions Llc | Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle |
US9034389B2 (en) | 2009-03-11 | 2015-05-19 | Stable Solutions Llc | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
US8993625B2 (en) | 2009-03-11 | 2015-03-31 | Stable Solutions Llc | Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle |
DK2440065T3 (en) * | 2009-06-12 | 2018-12-10 | Calanus As | COPYPOD OIL COMPOSITION, FORMULATIONS CONTAINING THE OIL COMPOSITION, AND ITS APPLICATION FOR REDUCING VISCAL FAT COLLECTION, IMPROVEMENT OF GLUCOSET TOLERANCE AND PREVENTION OR TREATMENT OF PATIENTS |
US20110015154A1 (en) * | 2009-07-20 | 2011-01-20 | Kellermann Gottfried H | Supporting acetylcholine function |
US20110098265A1 (en) * | 2009-10-28 | 2011-04-28 | Neuroscience, Inc. | Methods for reducing cravings and impulses associated with addictive and compulsive behaviors |
AU2012251818B2 (en) * | 2011-05-03 | 2017-04-13 | Alfasigma S.p.A | Composition useful for the treatment of lipid metabolism disorders |
CN103945840A (zh) * | 2011-08-26 | 2014-07-23 | 国立大学法人大阪大学 | 糖尿病性心血管并发症的预防/治疗剂 |
GB201223370D0 (en) * | 2012-12-24 | 2013-02-06 | Univ Tartu | Method of treatment using lactobacillus fermentum ME-3 |
AU2013404985B2 (en) * | 2013-11-05 | 2017-06-15 | Hill's Pet Nutrition, Inc. | Methods and compositions for improving kidney function |
US11591288B2 (en) | 2017-08-23 | 2023-02-28 | Gavish-Galilee Bio Applications Ltd. | Compositions and methods for treating atherosclerotic cardiovascular disease |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56115736A (en) * | 1980-02-19 | 1981-09-11 | Kagakuhin Kensa Kyokai | Separation and purification of eicosapentaenoic acid and docosahexaenoic acid |
DE3026368A1 (de) * | 1980-07-11 | 1982-02-18 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion |
WO1988001861A1 (en) * | 1986-09-17 | 1988-03-24 | Baxter Travenol Laboratories, Inc. | Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic, vascular, cardiovascular, and/or thrombotic diseases |
US4918104A (en) * | 1987-06-16 | 1990-04-17 | Weiss Howard S | Method and composition for increasing the concentration of omega-3 polyunsaturated fatty acids in poultry and poultry eggs and poultry and eggs resulting therefrom |
DE3726299A1 (de) * | 1987-06-26 | 1989-02-23 | Dietl Hans | Fettemulsion zur intravenoesen anwendung |
JP2839276B2 (ja) * | 1989-01-23 | 1998-12-16 | 日本分光工業株式会社 | 超臨界流体抽出・分離方法及び装置 |
US4968719A (en) * | 1989-04-03 | 1990-11-06 | Sigma Tau, Industrie Farmaceutiche Riunite Spa | Method for treating vascular disease |
JPH0394655A (ja) * | 1989-09-06 | 1991-04-19 | Otsuka Pharmaceut Co Ltd | 栄養補給用組成物 |
DE4012894C2 (de) * | 1990-04-23 | 1998-11-12 | Werner Dr Gielsdorf | Pharmazeutisches Mittel zur Behandlung von Störungen des Fettstoffwechsels |
SE9101642D0 (sv) * | 1991-05-30 | 1991-05-30 | Kabi Pharmacia Ab | Phospholipids |
IT1254314B (it) * | 1992-03-27 | 1995-09-14 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari. |
IT1254331B (it) * | 1992-04-23 | 1995-09-14 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico. |
GB9214247D0 (en) * | 1992-07-04 | 1992-08-19 | Stephan Peter M | Composition for use as a food or food supplement |
US5308832A (en) * | 1992-07-27 | 1994-05-03 | Abbott Laboratories | Nutritional product for persons having a neurological injury |
IT1263004B (it) * | 1992-10-08 | 1996-07-23 | Sigma Tau Ind Farmaceuti | Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti. |
IT1256705B (it) * | 1992-12-21 | 1995-12-12 | Sigma Tau Ind Farmaceuti | Procedimento per la preparazione di l-(-)-carnitina a partire da un prodotto di scarto avente opposta configurazione. |
-
1995
- 1995-12-21 IT IT95RM000835A patent/IT1277953B1/it active IP Right Grant
-
1996
- 1996-11-21 EP EP96118681A patent/EP0780124B1/en not_active Expired - Lifetime
- 1996-11-21 PT PT96118681T patent/PT780124E/pt unknown
- 1996-11-21 ES ES96118681T patent/ES2169197T3/es not_active Expired - Lifetime
- 1996-11-21 DE DE69618158T patent/DE69618158T2/de not_active Expired - Lifetime
- 1996-11-21 AT AT96118681T patent/ATE210977T1/de active
- 1996-11-21 DK DK96118681T patent/DK0780124T3/da active
- 1996-11-22 US US08/755,310 patent/US5753703A/en not_active Expired - Lifetime
- 1996-11-26 TW TW085114597A patent/TW522013B/zh active
- 1996-11-29 CA CA002191645A patent/CA2191645C/en not_active Expired - Fee Related
- 1996-12-16 JP JP8335456A patent/JPH09176005A/ja active Pending
- 1996-12-18 KR KR1019960067231A patent/KR970032853A/ko not_active Application Discontinuation
- 1996-12-20 ZA ZA9610769A patent/ZA9610769B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DK0780124T3 (da) | 2002-04-15 |
KR970032853A (ko) | 1997-07-22 |
ITRM950835A0 (it) | 1995-12-21 |
ATE210977T1 (de) | 2002-01-15 |
PT780124E (pt) | 2002-06-28 |
JPH09176005A (ja) | 1997-07-08 |
ITRM950835A1 (it) | 1997-06-21 |
EP0780124B1 (en) | 2001-12-19 |
EP0780124A1 (en) | 1997-06-25 |
ES2169197T3 (es) | 2002-07-01 |
ZA9610769B (en) | 1997-07-09 |
CA2191645C (en) | 2007-07-31 |
US5753703A (en) | 1998-05-19 |
CA2191645A1 (en) | 1997-06-22 |
DE69618158T2 (de) | 2002-07-18 |
TW522013B (en) | 2003-03-01 |
DE69618158D1 (de) | 2002-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1277953B1 (it) | Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per | |
IT1276253B1 (it) | Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi | |
ATE236627T1 (de) | Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure | |
PT1152755E (pt) | Acidos gordos essenciais destinados a prevencao de acidentes cardio-vasculares | |
AU4485689A (en) | Oral dosage forms of omega-3 polyunsaturated acids | |
PT764405E (pt) | Composicao nutricional | |
BG101993A (en) | Dialkylethers containing end carboxylic or tetrazole groups | |
BR0112073A (pt) | Combinações terapêuticas de ácidos graxos | |
DE69506642D1 (de) | Pharmazeutische Zubereitungen enthaltend mehrfach ungesättigte Fettsäuren zusammen mit antioxydativen Vitaminen und Provitaminen | |
EP2216318A3 (en) | Resolvins: Biotemplates for therapeutic interventions | |
YU59303A (sh) | Esencijalne n-3 masne kiseline u lečenju srčane insuficijencije i manjkavosti rada srca | |
IT1294227B1 (it) | Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione | |
IT1254314B (it) | Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari. | |
NO932843D0 (no) | Farmasoeytiske preparater | |
DK1414496T3 (da) | Farmaceutisk sammensætning indeholdende en kombination af PPAR-alpha, pravastatin og mindst en polyglycoliseret glycerid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |